Collaborative Drug Discovery

Collaborative Drug Discovery

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3M

Overview

Collaborative Drug Discovery (CDD) is a private, revenue-generating software company founded in 2004, headquartered in Burlingame, California. The company's core product, CDD Vault, is a comprehensive, cloud-based informatics platform that centralizes research data management, collaboration, and analysis for drug discovery and related life sciences. By breaking down data silos and structuring information for machine learning, CDD enables research organizations to increase productivity, safeguard intellectual property, and accelerate the path to discovery. The company operates on a SaaS business model, serving hundreds of organizations globally with a strong emphasis on user-centric design and scientific customer support.

Digital HealthAI / Machine Learning

Technology Platform

CDD Vault: A cloud-based, unified scientific data management platform integrating modules for entity registration, assay data management, visualization, electronic lab notebook (ELN), inventory, curve analysis, and AI/ML tools. It is designed to structure, secure, and facilitate collaboration on chemistry and biology data for drug discovery and life sciences research.

Funding History

3
Total raised:$3M
Grant$500K
Series A$2.5M
SeedUndisclosed

Opportunities

The growing adoption of AI/ML in drug discovery creates a strong demand for platforms that can structure diverse data to be 'AI-ready.' The trend toward decentralized, collaborative research models (virtual biotechs, CRO partnerships) favors cloud-based, secure collaboration tools like CDD Vault.
Expansion into adjacent verticals such as agritechnology and consumer goods represents new market segments.

Risk Factors

Faces intense competition from both established laboratory informatics vendors and new AI-native platforms.
A downturn in biotech funding could reduce demand from its core startup customer segment.
As a cloud-hosted service managing critical IP, it bears significant risk from potential security breaches or service outages.

Competitive Landscape

Competes in the lab informatics and ELN market against companies like Dotmatics, Benchling (primarily for biology), IDBS, and various electronic lab notebook providers. Differentiation lies in its specific focus on collaborative, cloud-based discovery data for both chemistry and biology, its user-friendly design for rapid adoption, and its integrated AI/ML capabilities within a unified platform.